Trulieve Q3: $275M revenue, $93M operating cash flow, net loss $25M, cuts debt

Trulieve Cannabis Corp.

2023-Q3 EPS reported -$2.09 revenue$842,219,000

Revenue $275M, GAAP gross margin 52%, net loss $25M, adj. net loss $15M.
EBITDA $74M (27% revenue), adj. EBITDA $78M (28% revenue).
Cash from ops $93M, free cash flow $87M in Q3; FY2023 outlook: at least $100M ops, $70M FCF.
Reduced debt: bought $57M face of 2026 notes at 16.5% discount; redeemed $130M of 2024 notes, saving $20M interest.
Opened 5 new dispensaries; Maryland traffic up 235% QoQ with adult-use launch.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Trulieve Cannabis Corp. reported the quarter ended September 30, 2023 results: revenue $275 million, net income net loss of $25 million. Guidance raised.

Period: the quarter ended September 30, 2023
Revenue: $275 million
Net income: net loss of $25 million
Guidance: raised
Result: reported results

Exact text from the filing

Generally Accepted Accounting Principles unless otherwise indicated. Numbers may not sum perfectly due to rounding. Q3 2023 Financial and Operational Highlights* • Revenue of $275 million, with 96% of revenue from retail sales. • Achieved GAAP gross margin of 52%, with gross profit of $143 million. • SG&A expenses lowered by $2 million sequentially to $94 million.

View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

Trulieve Cannabis Corp. filing history →

Source: SEC EDGAR

accession 0001628280-23-038007

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.